{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "ELVR",
  "name": "Elevra Lithium Limited",
  "url": "https://frontierpicks.com/dossiers/ELVR/",
  "json_url": "https://frontierpicks.com/dossiers/ELVR.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Lithium-recovery narrative re-accelerating off a low base: GFEX carbonate turned (LC2609 CNY 146,360/t on 2026-08-10, +6.24% in six sessions) and on 2026-08-21 Elevra signed a binding 7-year, 144,000 dmt/yr take-or-pay offtake with Mangrove Lithium carrying a floor above NAL's cost of production. The 2026-08-28 FY26 report with first FY27 guidance is the binary, and RSI(14) 79.7 means it is met extended.",
  "invalidation_trigger": "A weekly close below $60 gives back the entire August advance and re-establishes the downtrend the 2026-08-07 non-confirmation interrupted; secondary break is the 2026-08-28 FY26 report landing with FY27 spodumene guidance below FY26's ~197,968 dmt, or the C$366M NAL expansion deferred rather than sanctioned.",
  "catalyst_date": "2026-08-28",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "critical-materials-rare-earths",
    "freight-logistics",
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Thin Nasdaq ADR; ASX:ELV in AUD is the price-setting line and the ADR can dislocate from it on low-volume sessions.",
    "Australian issuer with a 30 June fiscal year end, reporting on Form 6-K. No US-style quarterly EPS event or conference-call cadence.",
    "Presentation currency was changed to USD, advised with the December 2025 quarterly report, so older AUD-denominated comparisons are not like-for-like.",
    "Revenue is realized-price driven with contractual lags between spot spodumene and recognised price; record production volumes do not map to cash generation.",
    "Sell-side coverage is thin (roughly three analysts on the ASX line), so consensus targets move in large steps on single revisions.",
    "Mangrove offtake tonnes are conditional on Mangrove reaching FID by 2028-12-31 and commercial operation within three years of it; no FY27 revenue effect."
  ],
  "body_markdown": "\n_All prices below are public market data. The reference close is the 2026-08-21 close of $67.76._\n\n## ELVR — Elevra Lithium Limited\n\n## Current Thesis\nThe divergence flagged in early August resolved upward. On 2026-08-07 the ADR closed $60.34 with RSI(14) at 58.8 while the Guangzhou carbonate contract was making a five-month low; on 2026-08-21 it closed $67.76 with RSI(14) at 79.7. Two dated events sit under that move. First, the commodity turned: SunSirs reports the most-active GFEX lithium carbonate contract LC2609 closing CNY 146,360/t on 2026-08-10, up 6.24% over six sessions from an early-August low near CNY 136,000, then trading through CNY 150,000 intraday on 2026-08-12 to close CNY 149,700. Second, on 2026-08-21 Elevra executed a binding seven-year spodumene concentrate supply agreement with Mangrove Lithium covering North American Lithium output — the first contracted tonnage with a stated price floor above NAL's cost of production and no ceiling.\n\nThe leg an investor would be buying is therefore no longer \"wait for lithium to recover\". It is narrower and more checkable: a producer whose realized price collapsed 37% QoQ in the June quarter has, within three weeks, seen its underlying commodity bottom and locked a floor-priced take-or-pay contract for the bulk of a future production base. The shares are still 33.8% below the $102.33 52-week high and down 29.6% over three months. Nothing in the recovery is confirmed by structure yet, and the FY26 full-year report with first FY27 guidance lands 2026-08-28.\n\n## Bull Case\n- **First floor-priced offtake, signed 2026-08-21.** Initial term seven years plus a seven-year renewal; 122,000 dmt of SC6-equivalent in Year 1 rising to 144,000 dmt from Year 2 on a take-or-pay footing; an option for Mangrove to lift volumes up to 20% annually subject to NAL capacity and Elevra approval; up to 72,000 dmt per 12-month period purchasable before commercial operation. Pricing is market-linked and grade-adjusted with a floor stated to sit above NAL's cost of production, and the ceiling contemplated in the 2026-02-10 non-binding MoU was removed.\n- **Volume context.** FY26 NAL production was ~197,968 dmt (Quarterly Activities Report, 2026-07-28). Contracted Year-2 volume under the Mangrove agreement is 144,000 dmt.\n- **The commodity stopped falling.** Battery-grade lithium carbonate spot averaged CNY 148,000/t on 2026-08-12 per SunSirs, up CNY 3,250/t on the day, versus the CNY 136,800/t GFEX low printed 2026-07-22.\n- **Balance sheet.** Cash US$255M and net cash US$200M at 30 June 2026; the US$55M prepayment facility was reduced by US$9M in July (2026-07-28 report).\n- **Expansion economics restated upward.** The updated NAL study released 2026-07-28 carries incremental post-tax NPV8% of C$969M on C$366M of capex, on a staged approach the company says pulls production growth forward by two years.\n- **Portfolio simplification is converting to cash.** E45/2364 sold to Wildcat for $16M plus a royalty, completed 2026-08-07; the Ewoyaa (Ghana) sale to Zhejiang Huayou Cobalt for ~US$71M is guided to complete in Q3 CY26.\n\n## Bear Case\n- **The Mangrove tonnes are conditional and distant.** Mangrove must secure project financing, reach Final Investment Decision by 2028-12-31, and achieve commercial operation at a minimum 50% of nameplate within three years of that FID, for a 20,000 tpa LCE electrochemical refinery in Eastern Canada that does not yet exist. Nothing in the agreement produces FY27 revenue. Execution risk on the offtake sits with a private counterparty's ability to fund a greenfield plant.\n- **The June quarter was a revenue break, not a price wobble.** Q4 FY26 revenue US$31M (−61% QoQ) on sales of 33,977 dmt (−39% QoQ) at a realized US$921/dmt (−37% QoQ), against production of 54,479 dmt at 5.0% grade. Legacy contract pricing rolled off; realized price now tracks spot with a lag.\n- **The rebound is small relative to the break.** CNY ~146–150k/t is still roughly a quarter below the two-year high above CNY 200,000/t set in mid-May 2026.\n- **Restart supply has not gone away.** MinRes's Bald Hill (~140,000 dmt SC6/yr) and Core Lithium's Finniss restart are the supply additions the July sell-off discounted.\n- **Coverage is thin.** Roughly three analysts cover the ASX line; consensus 12-month target A$15.93 (high A$18.30, low A$14.50) as of 2026-08-08. A single downgrade moves that figure in a large step.\n\n## Setup & Price Structure\nThe narrative is **accelerating**, and three dates carry it — the commodity turn on 2026-08-10/2026-08-12, the FY26 results advisory issued 2026-08-17 confirming a 2026-08-28 report and webcast, and the binding Mangrove agreement on 2026-08-21. Attention is new (a first binding long-term contract, not a restatement), and the flow is expanding rather than moderating.\n\nThe crowding evidence, stated as observables rather than a verdict: RSI(14) at 79.7 on 2026-08-21 versus 58.8 two weeks earlier on 2026-08-07 — the momentum reading is at the top of its own range while price sits 33.8% under the 52-week high, so the stretch is against the short-term advance, not against a completed base. A scheduled binary is five trading sessions out. The May 2026 funding package (US$196M institutional placement at A$12.20, US$102M Canada Growth Fund convertible notes in two tranches, US$11M share purchase plan) was raised before the price broke and is a standing dilution mechanism rather than issuance into this strength; no new equity raise has been announced since. Insider activity is not observable in Form 4 shape here — an Australian issuer discloses director dealings via ASX Appendix 3Y.\n\nStructurally, the August advance began from the $60.34 area on 2026-08-07, which held above the July shelf and did not confirm the commodity's 2026-07-22 low. That non-confirmation is the whole structural argument; it has not yet been joined by a reclaim of any longer-dated level, and the $102.33 high is far away.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-28** — FY26 Full Year Report and Annual Report, with the first FY27 guidance. Investor webcast 9.30am AEST 2026-08-28 (7.30pm EDT 2026-08-27). Confirmed in the company's FY26 Financial Results and Annual Report Advisory dated 2026-08-17.\n- **~2026-09-30 (est.)** — Completion of the Ewoyaa (Ghana) sale to Zhejiang Huayou Cobalt for ~US$71M cash, guided to Q3 CY26 in the 2026-07-28 report.\n\n## What Would Change Our Mind\nThe cleanest break is fundamental and arrives on 2026-08-28: FY27 spodumene guidance set below FY26's ~197,968 dmt, or FY27 unit economics implying a realized price at or under the Q4 FY26 US$921/dmt, would say the June-quarter collapse is the new run-rate rather than a legacy-pricing artefact. A second break is the C$366M NAL expansion being deferred rather than sanctioned, which removes the C$969M NPV from the near-term case; sanctioning it into an unrecovered price consumes the US$200M net cash that currently underwrites the story, so both outcomes need reading against the guidance.\n\nOn price, a weekly close below $60 gives back the entire August advance and re-establishes the downtrend that the 2026-08-07 non-confirmation interrupted. On the commodity, a GFEX close back under the 2026-07-22 low of CNY 136,800/t would say the August rebound was a short-covering episode. On the offtake, any indication that Mangrove's project financing has stalled — or the FID clock running toward 2028-12-31 without funding announced — reduces the 2026-08-21 agreement to a press release.\n\n## Correlation Notes\n- ELVR is a thinly traded Nasdaq ADR; ASX:ELV in AUD is the price-setting line, and the ADR both lags it by a session and carries AUD/USD translation. Divergences between the two on low volume are a liquidity artefact, not information.\n- Primary driver is the GFEX lithium carbonate curve and Australian spodumene benchmarks; the name trades with PLS, MinRes, ALB and SQM and with lithium-basket ETFs, more tightly than with any equity index.\n- Company-specific decoupling from the complex has now happened twice in a month — the 2026-07-22 non-confirmation and the 2026-08-21 offtake pop — so peer read-across is weaker than usual until 2026-08-28 resets the fundamentals.",
  "first_seen": "2026-04-22",
  "last_analyzed": "2026-08-22T08:24:57+00:00",
  "last_synthesized": "2026-08-22",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}